SV1995000018A - Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. - Google Patents

Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.

Info

Publication number
SV1995000018A
SV1995000018A SV1995000018A SV1995000018A SV1995000018A SV 1995000018 A SV1995000018 A SV 1995000018A SV 1995000018 A SV1995000018 A SV 1995000018A SV 1995000018 A SV1995000018 A SV 1995000018A SV 1995000018 A SV1995000018 A SV 1995000018A
Authority
SV
El Salvador
Prior art keywords
eventually
hydrogen
atoms
radical
erythromycin
Prior art date
Application number
SV1995000018A
Other languages
English (en)
Spanish (es)
Inventor
Constantin Agouridas
Jean Francois Chantot
Alexis Denis
Odile Le Martret
Yannick Benedetti
Original Assignee
Roussel Uclaf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussel Uclaf filed Critical Roussel Uclaf
Publication of SV1995000018A publication Critical patent/SV1995000018A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
SV1995000018A 1994-04-08 1995-04-07 Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos. SV1995000018A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9404154A FR2718450B1 (fr) 1994-04-08 1994-04-08 Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Publications (1)

Publication Number Publication Date
SV1995000018A true SV1995000018A (es) 1997-10-24

Family

ID=9461886

Family Applications (1)

Application Number Title Priority Date Filing Date
SV1995000018A SV1995000018A (es) 1994-04-08 1995-04-07 Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.

Country Status (49)

Country Link
US (2) US5656607A (https=)
EP (1) EP0676409B1 (https=)
JP (1) JP3000023B2 (https=)
KR (1) KR100317148B1 (https=)
CN (1) CN1059445C (https=)
AP (1) AP587A (https=)
AT (1) ATE234853T1 (https=)
AU (1) AU684939B2 (https=)
BG (1) BG61916B1 (https=)
BR (1) BR9506147A (https=)
CA (1) CA2164638C (https=)
CO (1) CO4370097A1 (https=)
CZ (1) CZ296005B6 (https=)
DE (1) DE69529934T2 (https=)
DK (1) DK0676409T3 (https=)
DZ (1) DZ1869A1 (https=)
EE (1) EE04498B1 (https=)
ES (1) ES2189820T3 (https=)
FI (1) FI111264B (https=)
FR (1) FR2718450B1 (https=)
GB (1) GB2288174A (https=)
GE (1) GEP19991836B (https=)
HR (1) HRP950217B1 (https=)
HU (1) HU215396B (https=)
IL (1) IL112954A (https=)
IS (1) IS1865B (https=)
JO (1) JO1850B1 (https=)
LV (1) LV11182B (https=)
MA (1) MA23501A1 (https=)
MD (1) MD663G2 (https=)
MY (1) MY114672A (https=)
NO (1) NO308361B1 (https=)
NZ (1) NZ284498A (https=)
OA (1) OA10200A (https=)
PE (1) PE2896A1 (https=)
PL (1) PL180837B1 (https=)
PT (1) PT676409E (https=)
RO (1) RO115634B1 (https=)
RU (1) RU2141965C1 (https=)
SA (1) SA97170757A (https=)
SI (1) SI0676409T1 (https=)
SK (1) SK284079B6 (https=)
SV (1) SV1995000018A (https=)
TN (1) TNSN95026A1 (https=)
TW (1) TW316908B (https=)
UA (1) UA44705C2 (https=)
WO (1) WO1995027720A1 (https=)
YU (1) YU49221B (https=)
ZA (1) ZA952059B (https=)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2732023B1 (fr) * 1995-03-22 1997-04-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2742757B1 (fr) * 1995-12-22 1998-01-30 Roussel Uclaf Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2745289B1 (fr) * 1996-02-28 1998-05-29 Roussel Uclaf Nouveaux derives de l'acide 1(2h) quinoleine carboxylique, leur procede de preparation et leur application a la synthese de produits doues de proprietes antibiotiques
US5750510A (en) * 1997-04-04 1998-05-12 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
AU710532B2 (en) * 1996-05-07 1999-09-23 Abbott Laboratories 3-descladinose-2,3-anhydroerythromycin derivatives
FR2748746B1 (fr) * 1996-05-14 1998-08-14 Hoechst Marion Roussel Inc Nouveau procede d'isomerisation du radical methyle en 10 de derives de l'erythromycine
FR2751656B1 (fr) * 1996-07-24 1998-10-16 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
DE69733422T2 (de) * 1996-09-04 2006-05-04 Abbott Laboratories, Abbott Park 6-0-substituierte ketoliden mit antibakteriellen wirkung
UA51730C2 (uk) * 1996-09-04 2002-12-16 Ебботт Лабораторіз 6-o-заміщені кетоліди з антибактеріальною активністю, спосіб їх одержання (варіанти), фармацевтична композиція та спосіб регулювання бактеріальної інфекції у ссавців
FR2757168B1 (fr) * 1996-12-12 1999-06-11 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
FR2760017B1 (fr) * 1997-02-27 1999-04-30 Hoechst Marion Roussel Inc Nouveaux derives de l'erytromycine, leur procede de preparation et leur application comme medicaments
AU4472897A (en) * 1997-03-10 1998-09-29 Taisho Pharmaceutical Co., Ltd. Erythromycin a derivatives
US6140479A (en) * 1997-03-24 2000-10-31 Taisho Pharmaceuticals Co., Ltd. Erythromycin a derivatives
WO1998051696A1 (en) * 1997-05-09 1998-11-19 Pfizer Products Inc. Erythromycin derivatives
US5922683A (en) * 1997-05-29 1999-07-13 Abbott Laboratories Multicyclic erythromycin derivatives
EP0988308A1 (en) * 1997-06-11 2000-03-29 Pfizer Products Inc. 9-oxime erythromycin derivatives
FR2771008B1 (fr) * 1997-11-17 2000-04-28 Hoechst Marion Roussel Inc Utilisation des ketolides pour la preparation de compositions pharmaceutiques destinees a prevenir les complications thrombotiques arterielles liees a l'atherosclerose
AP1060A (en) * 1998-01-02 2002-04-23 Pfizer Prod Inc Novel erythromycin derivatives.
HRP980189B1 (en) * 1998-04-06 2004-04-30 Pliva Pharm & Chem Works Novel 15-membered lactams ketolides
ES2243066T3 (es) * 1998-09-22 2005-11-16 Pfizer Products Inc. Antibioticos de carbamato y carbazato cetolida.
FR2786188B1 (fr) * 1998-11-24 2002-10-31 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
DE69933897T2 (de) 1998-12-10 2007-03-15 Pfizer Products Inc., Groton Carbamat- und Carbazatketolid-Antibiotika
EP1298138B1 (en) * 1998-12-10 2006-11-02 Pfizer Products Inc. Carbamate and Carbazate Ketolide Antibiotics
EP1749832A3 (en) * 1998-12-10 2008-03-26 Pfizer Products Incorporated Carbamate and carbazate ketolide antibiotics
FR2789392B1 (fr) * 1999-02-04 2001-10-05 Hoechst Marion Roussel Inc Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
US6054435A (en) * 1999-03-19 2000-04-25 Abbott Laboratories 6-O-substituted macrolides having antibacterial activity
ATE340183T1 (de) * 1999-04-16 2006-10-15 Kosan Biosciences Inc Antiinfektiöse makrolidderivate
CA2370743A1 (en) 1999-04-16 2000-10-26 Dennis Hlasta Ketolide antibacterials
US6590083B1 (en) 1999-04-16 2003-07-08 Ortho-Mcneil Pharmaceutical, Inc. Ketolide antibacterials
HUP0201516A3 (en) * 1999-05-24 2003-03-28 Pfizer Prod Inc 13-methyl-erythromycin derivatives, process for their preparation and pharmaceutical compositions containing them
CA2451391A1 (en) 2001-07-03 2003-01-16 Chiron Corporation C12 modified erythromycin macrolides and ketolides having antibacterial activity
US7332304B2 (en) 2002-07-01 2008-02-19 Arkion Life Sciences Llc Process and materials for production of glucosamine and N-acetylglucosamine
EP1638549A4 (en) * 2003-03-10 2011-06-15 Optimer Pharmaceuticals Inc NEW ANTIBACTERIAL AGENTS
CA2523134A1 (en) * 2003-04-25 2004-11-11 Chiron Corporation Pyridyl substituted ketolide antibiotics
US7163924B2 (en) * 2003-04-25 2007-01-16 Chiron Corporation Ketolide derivatives
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
JP5711135B2 (ja) 2008-10-24 2015-04-30 センプラ ファーマシューティカルズ,インコーポレイテッド 胃腸疾患を治療するための方法
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
ES2608285T3 (es) 2009-09-10 2017-04-07 Cempra Pharmaceuticals, Inc. Procedimientos para el tratamiento de paludismo, tuberculosis y enfermedades por MAC
MX361413B (es) 2010-03-22 2018-12-05 Cempra Pharmaceuticals Inc Star Formas cristalinas de un macrólido y usos para las mismas.
CN102917708B (zh) 2010-05-20 2015-11-25 森普拉制药公司 制备大环内酯和酮内酯及其中间体的方法
EP2613630A4 (en) 2010-09-10 2014-01-15 Cempra Pharmaceuticals Inc HYDROGEN BOND FOR THE PREPARATION OF FLUOROCHETOLIDES FOR THE TREATMENT OF DISEASES
NZ700182A (en) 2012-03-27 2017-02-24 Cempra Pharmaceuticals Inc Parenteral formulations for administering macrolide antibiotics
AU2014239959A1 (en) 2013-03-14 2015-10-01 Cempra Pharmaceuticals, Inc. Methods for treating respiratory diseases and formulations therefor
CN105188712A (zh) 2013-03-15 2015-12-23 森普拉制药公司 用于制备大环内酯抗菌剂的收敛方法
JP6437523B2 (ja) 2013-04-04 2018-12-12 プレジデント アンド フェローズ オブ ハーバード カレッジ マクロライドならびにそれらの調製および使用の方法
CN106998685A (zh) * 2014-10-08 2017-08-01 哈佛大学的校长及成员们 14‑元酮内酯及其制备和使用方法
EP3273969A4 (en) 2015-03-25 2018-11-21 President and Fellows of Harvard College Macrolides with modified desosamine sugars and uses thereof
MD1222Z (ro) * 2017-05-31 2018-08-31 ИНСТИТУТ ЭЛЕКТРОННОЙ ИНЖЕНЕРИИ И НАНОТЕХНОЛОГИЙ "D. Ghitu" АНМ Procedeu de tratare a materialului săditor al florilor înainte de plantare
JP7199722B2 (ja) 2019-12-25 2023-01-06 旭精工株式会社 硬貨搬送振分機構及びそれを備えた硬貨識別搬送装置

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3868414A (en) * 1973-01-22 1975-02-25 Merck & Co Inc Tetrahydrofluorene carboxylic acids and related compounds
AT342770B (de) * 1975-04-07 1978-04-25 Thomae Gmbh Dr K Verfahren zur herstellung neuer erythromycinderivate
DE2842759A1 (de) * 1978-09-30 1980-04-10 Merck Patent Gmbh Basische aether, diese enthaltende pharmazeutische zubereitungen und verfahren zu ihrer herstellung
IL99995A (en) * 1990-11-21 1997-11-20 Roussel Uclaf Erythromycin derivatives, their preparation and pharmaceutical compositions containing them
FR2692579B1 (fr) * 1992-06-19 1995-06-02 Roussel Uclaf Nouveaux dérivés de la picromycine, leur procédé de préparation et leur application comme médicaments.
FR2697524B1 (fr) * 1992-11-05 1994-12-23 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
US5527780A (en) * 1992-11-05 1996-06-18 Roussel Uclaf Erythromycin derivatives
HRP930014A2 (en) * 1993-01-08 1994-08-31 Pliva Pharm & Chem Works 9-deoxo-9a-aza-11-deoxy-9a-homoeritromycin a 9a, 11-cyclic carbamates
FR2702480B1 (fr) * 1993-03-09 1995-04-28 Roussel Uclaf Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.

Also Published As

Publication number Publication date
PL180837B1 (pl) 2001-04-30
FR2718450A1 (fr) 1995-10-13
EE04498B1 (et) 2005-06-15
MD663F1 (ro) 1997-01-31
SK154695A3 (en) 1996-10-02
RO115634B1 (ro) 2000-04-28
NO308361B1 (no) 2000-09-04
SI0676409T1 (en) 2003-06-30
MD663G2 (ro) 1997-07-31
YU21695A (sh) 1997-12-05
AP9500743A0 (en) 1995-07-31
UA44705C2 (uk) 2002-03-15
GB2288174A (en) 1995-10-11
JPH07278177A (ja) 1995-10-24
YU49221B (sh) 2004-11-25
IS1865B (is) 2003-05-02
SA97170757A (ar) 2005-12-03
IL112954A0 (en) 1995-06-29
GB9506856D0 (en) 1995-05-24
HRP950217B1 (en) 2004-06-30
NO954942L (no) 1996-02-07
EP0676409B1 (fr) 2003-03-19
JO1850B1 (en) 1995-12-27
EP0676409A1 (fr) 1995-10-11
KR100317148B1 (ko) 2002-06-22
MY114672A (en) 2002-12-31
LV11182A (lv) 1996-04-20
CO4370097A1 (es) 1996-10-07
FI955913A0 (fi) 1995-12-08
IL112954A (en) 2000-07-16
TW316908B (https=) 1997-10-01
BG100150A (bg) 1996-06-28
FR2718450B1 (fr) 1997-01-10
CA2164638A1 (fr) 1995-10-19
IS4309A (is) 1995-11-17
CZ296005B6 (cs) 2005-12-14
AU684939B2 (en) 1998-01-08
PE2896A1 (es) 1996-02-12
US5760233A (en) 1998-06-02
NZ284498A (en) 1997-07-27
CN1059445C (zh) 2000-12-13
WO1995027720A1 (fr) 1995-10-19
ZA952059B (en) 1996-03-13
NO954942D0 (no) 1995-12-06
PL311871A1 (en) 1996-03-18
EE9500080A (et) 1996-12-16
DZ1869A1 (fr) 2002-02-17
GEP19991836B (en) 1999-11-05
FI955913A7 (fi) 1995-12-08
HU9503505D0 (en) 1996-02-28
JP3000023B2 (ja) 2000-01-17
RU2141965C1 (ru) 1999-11-27
AU2310795A (en) 1995-10-30
CZ322395A3 (en) 1996-08-14
DE69529934T2 (de) 2003-09-04
US5656607A (en) 1997-08-12
BR9506147A (pt) 1996-04-16
LV11182B (en) 1997-04-20
MA23501A1 (fr) 1995-12-31
CN1126997A (zh) 1996-07-17
ES2189820T3 (es) 2003-07-16
TNSN95026A1 (fr) 1996-02-06
PT676409E (pt) 2003-08-29
OA10200A (fr) 1996-12-18
HU215396B (hu) 1998-12-28
DK0676409T3 (da) 2003-06-23
HUT73772A (en) 1996-09-30
AP587A (en) 1997-04-29
HRP950217A2 (en) 1997-08-31
FI111264B (fi) 2003-06-30
SK284079B6 (sk) 2004-09-08
DE69529934D1 (de) 2003-04-24
CA2164638C (fr) 2003-12-30
BG61916B1 (bg) 1998-09-30
ATE234853T1 (de) 2003-04-15

Similar Documents

Publication Publication Date Title
SV1995000018A (es) Nuevos derivados de la eritromicina, su procedimiento de preparacion y su aplicacion como medicamentos.
ES476049A1 (es) Procedimiento para la preparacion de acilanilidas.
ES2107698T3 (es) Benzoilguanidinas sustituidas, procedimiento para su preparacion, su utilizacion como medicamento, como inhibidores del intercambio celular de na+/h+ o como agente de diagnostico, asi como medicamento que las contiene.
ES2058670T3 (es) Derivados amidicos y preparados dermatologicos que los contienen.
ES8801618A1 (es) Un procedimiento para preparar derivados de arilciclobutilalquilamina
ES464360A1 (es) Procedimiento para la obtencion de polibutadieno modificado con mercaptanos.
ES2062443T3 (es) Nuevos derivados peptidicos, su procedimiento de preparacion y las composiciones farmaceuticas que los contienen.
ES8603837A1 (es) Un procedimiento para la preparacion de derivados de pirazol
ES2063465T3 (es) Nuevos derivados n-sustituidos de alfa-mercapto-alquilaminas, su procedimiento de preparacion y los productos intermedios obtenidos, su aplicacion como medicamentos y composiciones que los contienen.
SE7704616L (sv) Sett att framstella nya 11-desoxi-prostaglandin-fÿ2-derivat
ES473464A1 (es) Procedimiento para la preparacion de nuevos derivados de 5,-11-dihidro-6h-pirido (2,3-b)(1,4)benzodiazepin-6-ona.
ES471809A1 (es) Procedimiento para preparar derivados de naftaleno
SE7706310L (sv) Omega-nor-aromatiska-13,14-dehydro-prostaglandiner och forfarande for framstellning av dem
ES2164868T3 (es) Reactivos, compuestos y procedimiento para la perfluoroalquilacion de compuestos nucleofilos, y derivados obtenidos.
IT1105096B (it) Procedimento per al produzione di gas di sintesi mediante ossidazione parziale
ES465322A1 (es) Un procedimiento para preparar compuestos e imericos de 4"- amino.
ES466127A1 (es) Un procedimiento para la preparacion de l-formil-indol-dihi-droindol dimero.
SE7904396L (sv) Sett att framstella arylettiksyraderivat
ES2155546T3 (es) Bencenosulfonil-ureas y -tioureas sustituidas, procedimiento para su preparacion y el uso de preparaciones farmaceuticas basadas en estos compuestos, asi como medicamentos que los contienen.
IT1095524B (it) Dispositivo per l'insegnamento dell'impiego dei pedali per uno strumento musicale elettronico
FR2381781A1 (fr) Derives de la guanine et medicament contenant ces substances
ES8704180A1 (es) Un procedimiento para preparar glicosidos
MX173423B (es) DERIVADOS DE 1-ARILSULFINIL-2-PIRROLIDINONA Y P ROCEDIMIENTO PARA SU PREPARACION R1, donde R1, en cualquier posición sobre el núcleR3 donde R2 y R3, identicos o difernetes represent
ES438757A1 (es) Un procedimiento de obtencion de las meta-trifluormetilben- cilaminas sustituidas al nitrogeno.
SE7607300L (sv) Tiaxantenforeningar samt forfarande for framstellning av dem

Legal Events

Date Code Title Description
FD Lapse
FD Lapse